Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$794 Buy
7
+1
+17% +$99 ﹤0.01% 598
2026
Q1
$565 Hold
6
﹤0.01% 647
2025
Q4
$593 Buy
+6
New +$581 ﹤0.01% 666

Other funds holding INCY

Aspect Partners's INCY Position: Q2 2026 in Review

Aspect Partners increased its Incyte (INCY) stake by 17% in Q2 2026, buying an estimated $99 and bringing the position to 7 shares worth $794. The position accounts for ﹤0.01% of the portfolio, ranked #598.

Aspect Partners first reported a position in INCY in Q4 2025 and has held it in 3 quarters since. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Aspect Partners held 7 shares of Incyte worth $794 as of Q2 2026.
  • Aspect Partners bought 1 Incyte share in Q2 2026, an estimated $99.
  • Incyte made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #598 holding.
  • Aspect Partners first reported a position in Incyte in Q4 2025 and has held it in 3 quarters since.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.